Agitation, seizures, and rigidity all generate heat
Not hypothalamic-mediated (explains antipyretic ineffectiveness)
Impaired heat dissipation
Peripheral vasoconstriction reduces radiation
Hot environment limits conduction and convection
Mitochondrial uncoupling in severe cases
Direct cellular thermogenic effect
Rhabdomyolysis mechanism
Prolonged muscle hyperactivity and seizures
ATP depletion in muscle cells
Calcium influx and cell death
Direct toxic effects on muscle
Cocaine-induced vasospasm causing ischemia
Myoglobin release and renal tubular injury
Direct tubular toxicity at low pH
Cast formation causing obstruction
Cardiac pathophysiology
Coronary vasospasm
Alpha-1 mediated in cocaine toxicity
Can occur with angiographically normal coronaries
Accelerated atherosclerosis from chronic use
Endothelial dysfunction
Premature CAD in young chronic users
Catecholamine-mediated cardiomyopathy
Takotsubo pattern from massive catecholamine surge
Apical ballooning pattern
Usually reversible over days to weeks
Therapeutic Considerations
GABAergic sedation rationale
Benzodiazepines address root cause of most complications
Reduce agitation and muscle hyperactivity
Blunt sympathetic overdrive
Reduce seizure activity
Treat hyperthermia indirectly via muscle relaxation
No ceiling dose principle
Large doses may be required in severe toxicity
Resistance common in chronic stimulant users
Escalate to second-line agents promptly if inadequate response
Beta-blocker controversy
Pure beta-blockers avoid due to unopposed alpha
Reflex increase in peripheral vasoconstriction
Hypertension worsening and coronary vasospasm
Mixed alpha-beta blockers debated
Labetalol may be safer than pure beta-blockers
Still not first-line due to theoretical concerns
AHA 2023 Guideline: adequate sedation is primary intervention for BP control
Duration of observation
Cocaine: relatively short half-life (30 to 90 minutes)
Metabolites may have longer cardiovascular effects
Clinical observation typically 4 to 6 hours
Methamphetamine: much longer duration (12 to 24 hours)
Extended observation required
Discharge timing adjusted accordingly
Synthetic cathinones: variable and often prolonged
Some cases require 24 to 48 hours observation
Evidence levels summary
Class I recommendation: benzodiazepines for agitation and seizures
AHA 2023 Guideline
Class I recommendation: external cooling for hyperthermia >40 degrees C
AHA 2025 Guidelines for Special Circumstances
Class IIa recommendation: avoid pure beta-blockers in cocaine toxicity
AHA 2023 Guideline
ACEP Level B: poison control consultation for all significant stimulant toxicity
Patient Discharge Instructions
copy discharge instructions
Discharge instructions for sympathomimetic toxicity
What happened
You were treated for an overdose or toxic reaction to a stimulant drug
Your symptoms were caused by the drug overstimulating your nervous system
There is no antidote for stimulant drugs; treatment is supportive care
What to expect at home
Fatigue and low mood are common after stimulant intoxication (crash phase)
Duration depends on the substance: cocaine effects last 4 to 8 hours; methamphetamine effects can last up to 24 hours
Muscle soreness may persist for several days if muscle breakdown occurred
Medications prescribed
Take as directed; do not miss follow-up blood work if ordered
Follow-up instructions
Primary care or addiction medicine within 1 to 2 weeks
Cardiology follow-up if heart involvement occurred
Blood work for kidney function and muscle enzymes if rhabdomyolysis present
Return to emergency department immediately for
Chest pain, pressure, or palpitations
Seizures
Muscle pain with dark or tea-colored urine
Decreased urine output
High fever or confusion
Severe headache
Weakness in any limb
Safety and harm reduction
Stimulant drugs can cause heart attacks and strokes even in young healthy people
Mixing stimulants with other drugs dramatically increases the risk of death
Avoid using stimulants alone; have someone present
Avoid hot environments and stay hydrated if using
Help is available for substance use disorder; ask your doctor for a referral
References
Guidelines and key sources
AHA 2025 Resuscitation Guidelines
Cao D, Arens AM, Chow SL, et al.
Part 10: Adult and Pediatric Special Circumstances of Resuscitation
2025 American Heart Association Guidelines for CPR and ECC
Circulation 2025
AHA 2023 Focused Update on Toxicology
Lavonas EJ, Akpunonu PD, Arens AM, et al.
2023 AHA Focused Update: Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning
Circulation 2023
ASAM/AAAP Clinical Practice Guideline 2024
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder
Journal of Addiction Medicine 2024
PMCID PMC11105801
AAAP Stimulant Use Disorder Guideline 2023
Batki S, Ciccarone D, Hadland SE, et al.
Management of Stimulant Use Disorder
American Academy of Addiction Psychiatry 2023
AHA/ACC Chest Pain Guideline 2021
Gulati M, Levy PD, Mukherjee D, et al.
2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain
Journal of the American College of Cardiology 2021
Additional references
Cardiac arrhythmias from stimulants
Dominic P, Ahmad J, Awwab H, et al.
Stimulant Drugs of Abuse and Cardiac Arrhythmias
Circ Arrhythm Electrophysiol 2022
PMID 34061335
Sympathomimetics toxicology review
Brown H, Pollard KA.
Drugs of Abuse: Sympathomimetics
Critical Care Clinics 2021
PMID 34053702
Cathinone polydrug toxicity
Cheng HC, Wang TY, Chang CM, Liao PH, Chen YC.
Fatal Polydrug Intoxication Involving Synthetic Cathinones in Taiwan
Journal of Emergency Medicine 2026
PMID 41719591
Toxin-induced delirium
Cai A, Cai X.
Toxin-Induced Acute Delirium
Neurologic Clinics 2020
PMID 33040861
ECG in the poisoned patient
Mitchell SH, Holstege CP, Brady WJ.
The Electrocardiogram in the Poisoned Patient
The Electrocardiagram in Emergency and Acute Care 2023
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.